SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-046136
Filing Date
2021-08-27
Accepted
2021-08-27 17:01:24
Documents
12
Period of Report
2021-08-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K alxo-8k_20210826.htm   iXBRL 8-K 35645
  Complete submission text file 0001564590-21-046136.txt   167747

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alxo-20210826.xsd EX-101.SCH 5697
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxo-20210826_lab.xml EX-101.LAB 20078
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxo-20210826_pre.xml EX-101.PRE 11943
5 EXTRACTED XBRL INSTANCE DOCUMENT alxo-8k_20210826_htm.xml XML 3680
Mailing Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 211219926
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences